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Chlamydia trachomatis infection is a primary cause of reproductive tract diseases including 17 
infertility. Previous studies showed that this infection alters physiological activities in mouse 18 
oviducts. Whether this occurs in the uterus and cervix has never been investigated. This study 19 
characterized the physiological activities of the uterine horn and the cervix in a Chlamydia 20 
muridarum (Cmu) infected mouse model at three infection time-points 7-, 14- and 21 days 21 
post infection (dpi). Cmu infection significantly decreased contractile force of spontaneous 22 
contraction in the cervix (7- and 14dpi; P<0.001 and P<0.05, respectively) but this effect was 23 
not observed in the uterine horn. The responses of the uterine horn and cervix to oxytocin 24 
were significantly altered by Cmu infection at 7dpi (P<0.0001), but such responses were 25 
attenuated at 14- and 21dpi. Cmu infection increased contractile force to prostaglandin 26 
(PGF2α) by 53-83% in the uterine horn. This corresponded with the increased messenger 27 
ribonucleic acid (mRNA) expression of Ptgfr that encodes for its receptor. However, Cmu 28 
infection did not affect contractions of the uterine horn and cervix to PGE2 and histamine. 29 
The mRNA expression of Otr and Ptger4 were inversely correlated with the mRNA 30 
expression of Il1b, Il6 in the uterine horn of Cmu-inoculated mice (P<0.01 – P<0.001), 31 
suggesting that the changes in the Otr and Ptger4 mRNA expression might be linked to the 32 
changes in inflammatory cytokines. Lastly, this study also showed a novel physiological 33 






Chlamydia trachomatis infection is the most frequently reported sexually transmitted 37 
infection in western countries (19, 27, 42). The disease causes clinically important 38 
morbidities and causes significant financial burden to individuals and healthcare services (76). 39 
This infection is easily curable with antibiotics, but the majority of patients are often 40 
asymptomatic, thus, leaving the infection untreated (37). Subsequently, ascension of the 41 
bacteria into the upper reproductive tract occurs and cause serious complications that affect 42 
reproductive tract function. Pelvic inflammatory disease, infertility, ectopic pregnancy and 43 
chronic pelvic pain (13, 70) are often the result of chronic and recurrent Chlamydia infections 44 
(39, 62) . There is also a strong link between Chlamydia trachomatis reproductive tract 45 
infection on pre-term birth and miscarriage (2, 3, 58, 61). A better understanding of the 46 
processes that lead to the development of Chlamydia-associated pathologies, in particular its 47 
effects on reproductive tract function, is required.    48 
In pre-clinical models, Chlamydia infection disrupts the pace-making activity of the 49 
mouse upper reproductive tract (i.e. oviducts), thus, affecting spontaneous contraction of 50 
these tissues (25, 26). This disrupted motility is a potential contributor to tubal infertility. 51 
Whether this extends to the lower region of the female reproductive tract is unknown. Like 52 
oviducts, the uterus and cervix contract spontaneously in the non-pregnant state in human and 53 
mouse (14, 15, 24, 36). Importantly, spontaneous contraction in the human female 54 
reproductive tract is believed to play an essential role in maintaining fertility. Although the 55 
exact functions of these contractions have not been fully elucidated, what is already known is 56 
that they help oocyte propulsion and menstrual shedding (43), sperm transportation (67) and 57 
perhaps the transportation or shedding of pathogens.  58 
Apart from spontaneous contraction, smooth muscles along the female reproductive 59 




For example, the hormone oxytocin, which is the prominent stimulant in the female 61 
reproductive tract, increases uterine (23, 34, 35, 64), cervical and vaginal motility (36). 62 
During parturition, increased expression of the oxytocin receptor along the female 63 
reproductive tract is essential for heightened uterine contraction during labour (65). 64 
Prostaglandin signalling is also recognized in modulating uterine motility (20). Of all the 65 
subtypes of prostaglandins, only PGF2α and PGE2 are known to modulate motility in the 66 
female reproductive tract (56, 68). These prostaglandins are also associated with pain in 67 
dysmenorrhea (38). In addition, mast cell mediators such as histamine, also modulate smooth 68 
muscle contractions along the female reproductive tract (69). Importantly, these mediators are 69 
essential in regulating smooth muscle contractions during parturition (49).  70 
In other viscera, notably the bladder and bowel, inflammation or infection are known 71 
to alter smooth muscle functions. This occurs in inflammatory bowel disease (53, 79), 72 
ulcerative colitis (48), interstitial cystitis (21), urinary tract infection (74) and cystic fibrosis 73 
(33). Inflammatory mediators can exert their effects by directly acting on smooth muscle cells. 74 
They can also stimulate the release of mediators from mast cells that have profound effects 75 
on smooth muscle function (63). In addition, these inflammatory mediators may also modify 76 
the sensitivity of smooth muscle cells to endogenous mediators by altering the expression of 77 
certain receptors (45). Evidence from preterm and term deliveries suggest that parturition is 78 
regulated by a series of inflammatory processes because inflammatory neutrophils and 79 
macrophages are observed in the uterus, decidua and cervix in both clinical and pre-clinical 80 
models during labour (32, 50). These immune cells, along with mast cells and chemokines, 81 
coordinate the timely contraction of the uterus, cervical ripening and dilation and rupture of 82 
the foetal membrane during parturition (1, 28, 32, 50). Chlamydia infection induces 83 
immunological alterations in the female reproductive tract (6, 8, 9, 29) but whether these 84 




It is now increasingly acknowledged that infection changes microbiota composition 86 
(11, 22) in the infected region and may alter the physiological function of an organ (4, 30). 87 
Evidence demonstrates that alterations in gut microbiota may lead to smooth muscle motility 88 
dysfunction (30, 66). The alteration in gut microbiota is also suggested to be a factor causing 89 
slow transit constipation (30, 55). The host and microflora interactions are essential in 90 
maintaining organ health and any alteration in the microbiota composition may disrupt this 91 
homeostasis. The changes in bacterial substances or end products of bacterial fermentation 92 
may change the immune response and neuroendocrine factors which in turn affect the 93 
physiological functions of the organ (4, 30). Chlamydia infection does not only alter the 94 
immunological response (8, 29, 44), it is also suggested to change the microbiota composition 95 
in the cervicovaginal region (4, 11). The collective evidence of alterations caused by 96 
Chlamydia infection suggest there could be a change in the physiological function of the 97 
uterus and cervix. Therefore, we compared smooth muscle contraction of mouse uterine horn 98 
and cervix in Chlamydia infection at three time-points. We also assessed the relationship 99 
between mRNA expression for receptors involved in smooth muscle contraction with 100 





Materials and Methods 103 
Ethics Statement 104 
All procedures were conducted in accordance with the Australian Code for the Care and Use 105 
of Animals for Scientific Purposes 8th Edition (2013) as endorsed by the National Health and 106 
Medical Research Council (NHMRC), the Australian Research Council, the Commonwealth 107 
Scientific Industrial Research Organisation and Universities Australia. All protocols were 108 
approved by The University of Newcastle Animal Care and Ethics Committee (A-2011-109).  109 
 110 
Mice 111 
Naïve specific pathogen-free female wild-type C57BL/6 mice of reproductive age (3 – 7 112 
months old; weighed 20-35g) were obtained from the Australian BioResources (Moss Vale, 113 
NSW, Australia) and housed 4 mice per cage in individually ventilated cages. Each cage was 114 
equipped with autoclaved corn cob bedding and a shelter, nesting paper, paper coils and a 115 
wooden tongue depressor for environmental enrichment. Mice were maintained on a 12-hour 116 
light-dark cycle in a room with controlled temperature (22 ± 2 °C) and humidity (30-117 
70%). They were fed ad libitum with autoclaved standard rat and mouse cubes (Specialty 118 
Feeds, WA, Australia) and water throughout the experimental period. Mice acclimatised for 119 
at least 5 days prior to experimentation. Before the mice were assigned into groups, they were 120 
monitored for general signs of health and well-being and therefore represented the uniform 121 
population. All treated mice were monitored daily for clinical signs of disease as part of the 122 
approved protocol. Intervention by veterinary treatment or euthanasia was indicated by the 123 
development of signs of severe disease. There were no animal deaths or interventions 124 
required as a result of our protocol. Their weight, appearance and behaviour were within 125 
normal parameters prior to being assigned to groups. All mice were euthanised by 126 






To replicate Chlamydia reproductive tract infection in human, we infected mice 130 
intravaginally with Chlamydia muridarum (Cmu) (52). This is a natural mouse pathogen that 131 
induces upper reproductive tract inflammation and pathology, characterized by the 132 
development of hydrosalpinx, similar to human C. trachomatis reproductive tract infection (6, 133 
9, 29, 52). At day 1, animals were subcutaneously injected with medroxyprogesterone acetate 134 
(PROVERA®, Pfizer, Australia; 2.5 mg in 200 µL saline) under isoflurane anaesthesia to 135 
ensure all mice were in the diestrus stage of their estrous cycle (6, 9, 29). At day 8, mice were 136 
allocated into two groups: sham-inoculated or Cmu-inoculated. Mice in the Cmu-inoculated 137 
group were infected by intravaginal inoculation of 5 × 104 inclusion forming units of Cmu 138 
(ATCC VR-123) in 10 µL sterile sucrose phosphate glutamate (SPG) buffer; while the sham-139 
inoculated mice were intravaginally inoculated with 10 µL of SPG buffer alone. All mice 140 
were under ketamine-xylazine anaesthesia (Troy Laboratories, Australia; 80 mg/kg:5 mg/kg 141 
IP; Ilium Ketamil® and Ilium Xylazil-20®) during the procedure. SPG buffer was used as the 142 
vehicle as it maintains viability of Chlamydia (6, 9, 29). Mice were monitored daily for 7-,14- 143 
and 21 days post-infection (dpi). Mice were sacrificed at the end of respective time-point by 144 
sodium pentobarbitone (Lethabarb, Virbac, Australia) overdose, and vaginal lavages were 145 
collected for estrous cycle stage confirmation as previously described (29, 36). The left 146 
uterine horn was dissected out, trimmed of visceral fat, snap-frozen in liquid nitrogen and 147 
stored at -80C for subsequent quantitative polymerase chain reaction (qPCR). The right 148 
uterine horn and cervix were placed in chilled physiological saline solution (PSS, 120 mM 149 
NaCl, 5 mM KCl, 2.5 mM CaCl2, 2 mM MgCl2, 25 mM NaHCO3, 1 mM NaH2PO4 and 10 150 





Measurement of cross-sectional area of oviducts 153 
The height and width of both oviducts were measured using a calliper and the cross-sectional 154 
area was calculated. Higher cross-sectional area indicates swelling of the oviducts. 155 
Development of hydrosalpinx and swelling of the oviducts indicate fluid accumulation which 156 
is caused by scarring and blockage of the oviducts and is one of the key pathological features 157 
of Chlamydia infections. Hydrosalpinx is the result of immune cell infiltration and 158 
inflammation (5, 18, 77). We have used measurement of hydrosalpinx to identify the 159 
development of Chlamydia-associated pathology in our model. 160 
 161 
Preparation of myometrial and cervical strips 162 
The detailed anatomy of our isolated preparations have been previously outlined relative to 163 
smooth muscle actin ((36); see also (78)). Right uterine horns were trimmed of connective 164 
tissue and opened along the mesometrial border. A uterine strip of 1 cm in length measured 165 
from the end of oviduct was prepared. Uterine strips were tied at both ends with thread that 166 
was subsequently attached to a hook at the base of the 4 mL tissue bath and a tension 167 
transducer (Grass FT03) respectively. For cervical preparations, tissue immediately caudal to 168 
the bicollis uterus was transected adjacent to the vaginal canals. The cervical incision was 169 
made at the anterior fornix and extended longitudinally towards the uterine horns. The tubular 170 
cervix was then uncoiled into a rectangular strip. Due to the firmer nature of the cervix tissue 171 
piercings were made near the cut edge with a 30G needle. String was then looped through the 172 
puncture and tissue was suspended in the tissue bath so the direction of force would be in 173 
similar direction to a dilating cervix. Tissues were then equilibrated at tension of 10 mN 174 
(cervix) and 5 mN (uteri) for 30 min in PSS at 37C before being challenged with 60 mM 175 
KCl (potassium chloride). Spontaneous contractions were recorded as previously described 176 




Cervices were kept in RNAlater® (Thermo Fisher Scientific, Scoresby, VIC, Australia), 178 
stored at 4℃ overnight, and finally stored at -80℃ until RNA extraction was performed for 179 
subsequent qPCR reaction.  180 
 181 
Contractile activity  182 
Contractile force was assessed by measuring peak amplitude relative to 60 mM KCl corrected 183 
for wet weight and expressed as %KCl while frequency of contractions were expressed as 184 
number of contractions per 5 minutes as outlined in (36). 60 mM KCl acted as the internal 185 
control for contractile force as it was not affected by Cmu infection in both cervix and uterine 186 
horns at the three time-points (Fig S1 -  DOI: 187 
https://doi.org/10.6084/m9.figshare.10317068.v1). Each tissue was equilibrated for 30 min 188 
before stimulation with 60 mM KCl (~2 min). Following KCl stimulation preparations were 189 
left for a further 30 minutes to determine baseline contractility before application of drugs. 190 
Oxytocin, PGF2α and PGE2 (Cayman Chemical, Ann Arbor, USA) were dissolved in 191 
dimethyl sulfoxide (DMSO). The final concentration of DMSO did not exceed 0.001%. 192 
Histamine (Sigma Aldrich, Missouri, USA) was dissolved in milli-Q water. 193 
Cumulative oxytocin dose responses were obtained by adding increasing 194 
concentrations into the organ bath every 5 min. In separate experiments, PGF2α (1 µM and 3 195 
µM), PGE2 (1 µM) and histamine (1 mM) were tested. The concentration for each mediator 196 
was based on previous studies (17, 54, 59). Each mediator was applied for 5 min before 197 
wash-off. Tissues were washed 3-5 times before the next drug was added. At the end of the 198 
experiment, tissues were contracted with 60 mM KCl again to ensure tissue viability. The 199 
contractile force was extracted using automated quantification in LabChart 8 Reader 200 




The change in contractile force of the spontaneous contractions evoked by PGF2α, 202 
PGE2 and histamine (∆ %KCl) was compared between the sham- and Cmu-inoculated mice.  203 
. 204 
RNA isolation, reverse-transcription PCR (RT-PCR) and qPCR 205 
Frozen tissues were thawed and squeezed dry of RNAlater®. Tissues were then homogenized 206 
in 500 µL of TRIzol® (Invitrogen, Mount Waverly, VIC, Australia) using a Tissue-Tearor 207 
stick homogenizer (BioSpec Products, Bartesville, OK) on ice. Total RNA was extracted 208 
according to the manufacturer’s instructions (TRIzol®, Invitrogen, Mount Waverly, VIC, 209 
Australia) (6, 9, 29) and was treated with DNase (Sigma-Aldrich). The end-product was 210 
reverse-transcribed to cDNA using M-MLV Reverse Transcriptase (Life Technologies, 211 
Thermo Fisher Scientific) and random hexamer primers (Bioline, Alexandria, NSW, 212 
Australia) in a T100™ Thermal Cycler (BioRad). qPCR was performed on a CFX384 Touch 213 
Real-Time PCR Detection System (Bio-Rad, Gladesville, NSW, Aus) using SYBR reagents 214 
(KAP Biosystems, MA, USA) and custom designed primers specific for Cmu ribosomal 16S 215 
rRNA; the inflammatory markers, Stat1, Stat6, Ifng, Cxcl1, Cxcl2, Il10, Mmp9, Il1b, Il6, 216 
Cxcl15, Tnfa; oxytocin receptor, Otr; and prostaglandin receptors, Ptgfr, Ptger1, Ptger2, 217 
Ptger3 and Ptger4. mRNA expression was calculated using 2-Ct relative to the reference 218 
gene hypoxanthine-guanine phosphoribosyl-transferase (Hprt) and expressed as relative 219 
expression. Primers used in this study are reported in Table 1.  220 
 221 
Statistical Analysis 222 
Tests for normality were performed on all data using Statistical Package for the Social 223 
Science v24 software (SPSS Inc., Chicago, IL, USA). GraphPad Prism Software v8 (San 224 
Diego, CA) was subsequently used for statistical analyses. All data are presented as means  225 




from different mice. Statistical significance was set at P<0.05. Statistical significance for 227 
comparisons between two groups was determined using either unpaired t-test for parametric 228 
data or Mann-Whitney U test for non-parametric data. Dose-response curves were fitted 229 
using Nonlinear Regression – log(agonist) vs. response (three parameters) model from 230 
GraphPad Prism v8, as previously described (47). Comparison of Fits under the Nonlinear 231 
Regression model was used for the comparison of best-fit curves, where the bottom plateau, 232 
EC50, and top plateau of best-fit curves was compared between sham- and Cmu-inoculated 233 
data. For comparison of changes in mRNA expression of inflammatory markers versus 234 
receptors, a Spearman’s correlation analysis of multi-variables was performed using 235 
GraphPad Prism v8 (San Diego, CA). Correlation coefficients r (rho) range from -1 to +1. 236 
Values lesser than 0 indicate an inverse relationship and values larger than 0 show a positive 237 







Pathology of Cmu infection 242 
We first confirmed productive Cmu infection in the upper reproductive tract by 243 
quantifying Cmu ribosomal 16S rRNA in the uterine horn. The presence of 16S rRNA 244 
indicates active infection (6). There was no 16S rRNA expression in sham-inoculated uterine 245 
horns while 16S rRNA was detected in the uterine horn of all Cmu-inoculated mice at 7-, 14- 246 
and 21dpi (Fig 1A). The highest bacterial load (peak infection) of 16S rRNA was observed at 247 
7dpi. Higher cross-sectional area was also observed in both the oviducts of Cmu-inoculated 248 
mice compared to the sham (Fig 1B and C), confirming the successful development of 249 
pathology in our model. As noted in previous studies (6, 8, 9, 29), Cmu infection significantly 250 
increased inflammatory cytokines in the uterine horn (Fig 2) and cervix (Fig 3) at all three 251 
time-points. 252 
 253 
Cmu reduced spontaneous contraction in the cervix but not in the uterine horn  254 
 Relative to 60 mM KCl contractions, spontaneous contractions were unaffected in the 255 
uterine horn of Cmu-inoculated mice at three time-points (Fig 4A – E). In contrast, 256 
spontaneous contraction in the cervix was reduced by 45.4% and 49.7% at 7- and 14dpi, 257 
respectively (Fig 4F - I). However, this phenomenon was restored to sham levels at 21dpi 258 
(Fig 4I). Contractile frequency of the cervix was not affected by Cmu infection at any time-259 
point post infection (Fig 4J).  260 
 261 
Effects of Cmu infection on mediator-induced contractions  262 
Oxytocin 263 





In parallel with the study by Gravina and co-workers (36), oxytocin modified uterine 266 
contractile force and frequency in mice (Fig 5A, D and G). To investigate the effects of Cmu 267 
infection on the uterine contractions to oxytocin, best-fit dose-response curves were 268 
compared between the sham- and Cmu-inoculated mice. A significant decrease in both the 269 
contractile force and frequency to oxytocin in Cmu-inoculated mice was observed at 7dpi 270 
(Fig 5B). Despite the decrease in uterine response to oxytocin, there was no significant 271 
change in the EC50 of oxytocin between the two groups (EC50 - 32.3±1.4 nM in sham-272 
inoculated; 42.4±1.9 nM in Cmu-inoculated; P=0.65).  273 
To further investigate the reason for the decreased uterine contractions to oxytocin at 274 
7dpi, we compared the mRNA expression of the oxytocin receptor – Otr in the uterine horn 275 
between the two groups. The Otr expression was significantly decreased in the Cmu-276 
inoculated uterine horns at 7dpi (Fig 5C), while Otr expression remained unchanged at 14- 277 
(Fig 5F) and 21dpi (Fig 5I).  278 
 279 
Cmu infection increased contractile force of the cervix to oxytocin at the early infection 280 
time-point 281 
In contrast to the uterine horn, a significant increase in contractile force to oxytocin 282 
was observed in the cervix of Cmu-inoculated mice at 7dpi (Fig 6A and B) but contractile 283 
frequency was not affected by Cmu infection. The EC50 in the two groups was also unaffected 284 
(EC50 – 2.0±0.3 µM in sham-inoculated; 1.3±0.2 µM in Cmu-inoculated; P=0.75). The 285 
response of cervix to oxytocin in Cmu-inoculated mice was not significantly different to 286 
sham levels at 14 and 21dpi (Fig 6E and H).  287 
In a separate cohort of mice, we found that 14dpi Cmu infection decreased mRNA 288 
expression of Otr in the cervix (refer to Fig 6F). However, there was no change in Otr 289 





Prostaglandins - PGF2α and PGE2 have differential effects on the cervix and uterine 292 
horn 293 
PGE2 elicited a differential response in the cervix and uterine horn 294 
Notably, we observed opposing responses elicited by PGE2 in both the uterine horn 295 
and cervix. PGE2 decreased contractile force in the uterine horn (Fig 7A) while it increased 296 
contractile force in the cervix (Fig 7B). To further assess if such differential responses to 297 
PGE2 was due to differences in receptor expression, mRNA expression for PGE2 receptors 298 
was compared between the uterine horn and cervix. The data were pooled from only sham-299 
inoculated mice of 7-, 14- and 21dpi, and the comparison was made between the cervix and 300 
uterine horn. Other than Ptger1, the cervix generally showed lower mRNA expression of 301 
receptors – Ptgfr, Ptger2, Ptger3 and Ptger4 (Fig 7C; n=24-29; Mann-Whitney U test; 302 
P<0.0001) compared to the uterine horn. Interestingly, Ptger2 expression was very low in the 303 
cervix compared to the uterine horn (relative expression of Ptger2 in the cervix – 304 
0.002±0.0004; uterine horn – 0.05±0.008).  305 
 306 
Cmu infection increased uterine contraction to PGF2α 307 
To investigate the effects of Cmu infection on the response to prostaglandins, PGF2α 308 
and PGE2, we compared uterine contractions between sham-inoculated and Cmu-inoculated 309 
mice. Cmu infection did not alter uterine contraction to PGF2α at 7dpi (Fig 8A and S2) but it 310 
significantly increased uterine contractile force at 14- (Fig 8C) and 21dpi (Fig 8E). We then 311 
compared the mRNA expression of PGF2α receptors – Ptgfr, Ptger3 and Ptger4 between the 312 
two groups. At 7dpi, the mRNA expression of Ptgfr, Ptger3 and Ptger4 were significantly 313 
lower in the uterine horn of Cmu-inoculated mice compared to sham (Fig 8B). At 14dpi, a 314 




mice. Also, at 14dpi, Ptger4 mRNA expression in the uterine horn was significantly 316 
decreased by Cmu infection (Fig 8D). Cmu infection also significantly increased Ptgfr 317 
mRNA expression in mouse uterine horn at 21dpi but did not alter the mRNA expression of 318 
Ptger3 and Ptger4 (Fig 8F).  319 
 320 
Cmu infection did not alter cervical response to PGF2α 321 
PGF2α induced contraction in the cervix of sham- and Cmu-inoculated mice (Fig S3 - 322 
DOI: https://doi.org/10.6084/m9.figshare.10317068.v1) at 7-, 14- and 21dpi. However, 323 
there was no significant difference in the cervical contraction to PGF2α between the sham- 324 
and Cmu-inoculated mice (Table 2).  325 
 326 
PGE2 327 
Cmu infection did not alter cervical and uterine contraction to PGE2 328 
The effects of Cmu infection on the cervical and uterine contractions to PGE2 were 329 
also investigated. Cmu infection did not alter physiological response of both the organs to 330 
PGE2 at all infection time-points (Tables 2 and 3).  331 
 332 
Histamine 333 
Cmu infection did not alter cervical and uterine contractions to histamine 334 
Histamine is one of the mediators released during mast-cell degranulation and it is 335 
also a potent modulator of smooth muscle contraction along the female reproductive tract (16, 336 
59). Thus, the effects of Cmu infection on the cervical and uterine contractions to histamine 337 
were also investigated. The cervical and uterine contractions to histamine were not different 338 






Correlation of cytokines with receptor mRNA expression in the uterine horn 342 
Because Cmu infection significantly altered uterine contractions to mediators, we next 343 
explored the relationship between cytokines and related receptors in the uterine horn, 344 
specifically the relationship between Il1b, Il6, Cxcl15 (analogue of human Il8 (46)) and Tnfa 345 
mRNA relative expression levels versus Otr, Ptgfr and Ptger4 mRNA relative expression 346 
levels. These cytokines are known to modulate female reproductive tract contraction (1) and 347 
their mRNA was also significantly increased in the uterine horn of Cmu-inoculated mice (Fig 348 
2 and Fig 3). We combined the data of Cmu-inoculated uterine horn from the three time-349 
points for Spearman’s correlation analysis. In our model, Otr was inversely correlated with 350 
Il1b and Il6 mRNA in the uterine horn (Fig 9; n=23; Spearman’s correlation; **P<0.01). 351 
Similarly, Ptger4 was also inversely correlated with Il1b and Il6 mRNA in the uterine horn 352 
(Fig 9; n=23; Spearman’s correlation; **P<0.01, ***P<0.001). There was no significant 353 





Discussion and Conclusion 356 
It has long been recognized that Chlamydia reproductive tract infections in women 357 
elicit a range of immunological responses in infected areas (40). Despite the alarming 358 
increase in Chlamydia reproductive tract infections, we do not know how these 359 
immunological changes affect the physiological functions of the female reproductive tract. 360 
Previous studies in mice showed that Chlamydia infection causes loss of pace-making ability 361 
in the oviduct, and this eventually impedes the transportation of the oocyte to the uterus (25, 362 
26). However, no studies have asked whether sexually transmitted infection-associated 363 
pathology extends to the uterus or the lower reproductive tract. Here, we focused on the 364 
uterine horn and cervix, as these organs are the main routes for microbe ascension that lead to 365 
subsequent complications (67).  366 
 Cmu infection did not affect spontaneous contractions in the uterine horn, indicating 367 
that smooth muscle pace-making property was not affected. In contrast, Cmu infection 368 
reduced the force of spontaneous contractions in the cervix during early infection time-points 369 
(7- and 14dpi) when the Cmu load was high, but not at 21 days when Cmu load was reduced. 370 
This suggests that there might be an association between the Cmu load and smooth muscle 371 
motility. Although the mechanisms underlying this correlation are unclear, findings in the 372 
gastrointestinal tract demonstrated the association of changes in microbiota with disrupted 373 
smooth muscle function. Whether a similar mechanism occurs in the reproductive tract 374 
remains to be determined (4, 11, 22, 57). Also, we cannot discount the possibility that force 375 
changes are a secondary consequence of oedema within the connective tissue that the muscle 376 
fibres connect with (51, 71).  377 
The responses of the uterine horn and cervix to oxytocin - the prominent stimulant for 378 




increase in both baseline tone and contractile frequency in the uterine horn but only evoked 380 
an increase in contractile frequency in cervix.  381 
We next compared the uterine contractions to oxytocin between the sham- and Cmu-382 
inoculated mice and showed that Cmu infection significantly reduced contraction of the 383 
uterine horn to oxytocin at early infection (7dpi). This was concomitant with a significant 384 
decrease in the Otr mRNA expression. However, at 14dpi and 21dpi, Cmu infection did not 385 
affect oxytocin evoked uterine contraction or the mRNA expression of Otr. This suggests that 386 
the response of uterine horn to oxytocin may only be affected in acute Cmu infection. The 387 
cervical contractions to oxytocin between the sham- and Cmu-inoculated mice were also 388 
compared. At 7dpi, the EC50 of oxytocin in the cervix was not different between Cmu- and 389 
sham-inoculated mice, and there was no difference in the Otr mRNA expression. While the 390 
maximum contraction of oxytocin relative to spontaneous contraction at 7dpi was increased 391 
in Cmu-inoculated cervix, this was more due to the reduced contractile force in spontaneous 392 
contraction than the increased total force to oxytocin. At 14dpi, Cmu infection did not affect 393 
the amplitude of the cervical contractions to oxytocin even though Otr mRNA expression 394 
was significantly decreased. Presumably post-transcriptional receptor expression is 395 
maintained (72) or downstream pathways are amplified that compensate for any decrease in 396 
receptor expression (12, 41).  397 
Cmu infection increased contractile force to PGF2α and the mRNA expression of 398 
Ptgfr, which encodes FP receptor, in the uterine horn at 14- and 21dpi. At 14dpi, there was 399 
also a marked decrease in the mRNA expression of Ptger4 encoding the EP4 receptor in the 400 
uterine horn. PGF2α induces contraction via FP receptor while the binding of PGF2α to EP4 401 
receptor mediates smooth muscle relaxation (10). Therefore, at 14dpi, both the potential 402 
increase in FP receptors and decrease in EP4 receptors would result in increased contractile 403 




affected by Cmu infection despite the change in receptor mRNA expression. This further 405 
underscores the limitations of extrapolating changes in mRNA expression with physiological 406 
function (12, 72).  407 
While Cmu infection did not change the responses of the uterine horn or cervix to 408 
PGE2, one striking observation is that PGE2 exerted opposing effects on these tissues in mice 409 
in diestrus phase of the estrous cycle. PGE2 abolished spontaneous contractions in the uterine 410 
horn but induced contractions in the cervix. We also discovered differential mRNA 411 
expression for genes encoding EP receptors between cervix and uterine horn. Specifically, 412 
Ptger2 mRNA was expressed at extremely low levels in the cervix compared to the uterine 413 
horn of C57BL/6 mice. Given the EP2 receptor is linked to smooth muscle relaxation, the 414 
differential response to PGE2 in the uterine horn and cervix is perhaps not surprising. This is 415 
the first study to demonstrate a differential physiological response to PGE2 in mouse cervix 416 
and uterine horn. Further investigation into physiological function by using receptor blockers 417 
will strengthen this finding.  418 
Our results suggest that inflammation subsequent to Chlamydia infection drives 419 
changes in receptor expression or downstream signalling pathways. We found that Il6 and 420 
Il1b mRNA expression was inversely correlated with the mRNA expression of Otr and 421 
Ptger4 in the uterine horn. Several studies have implicated Il6 with changes in Otr receptors. 422 
There are several Il response elements, including nuclear factor (NF)-Il6, which flanks both 423 
rat Otr and human OTR promoter regions (60, 80). Our findings were in line with a study 424 
conducted by Schmid and co-workers on human myometrial cells, where Il1b and Il6 425 
negatively regulated Otr gene expression (60). However, Fang and co-workers showed that 426 
there was no correlation between Il6 and Otr in non-pregnant rat uterine tissue (28). 427 
While our data shed light on altered physiology in the non-pregnant reproductive tract, 428 




cervix contractility is changed in late pregnancy compared with the non-pregnant state (36). 430 
Interestingly miscarriage is one of the complications associated with Chlamydia infections (2, 431 
7, 31, 75). How this might relate to altered smooth muscle function requires future 432 
investigation (73, 75). 433 
We have shown for the first time that Chlamydia infection can change smooth muscle 434 
motility in the female reproductive tract. Furthermore, Cmu infection differentially altered 435 
smooth muscle function and receptor mRNA expression of prostaglandin receptors (Ptgfr, 436 
Ptger2 and Ptger4) in mouse uterine horn compared with cervix. Our results suggest that 437 
Chlamydia-induced changes to reproductive tract physiology need to be extended below the 438 
oviduct to the entire female reproductive tract. 439 
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Figures and Legends 726 
 727 
Fig 1: Intravaginal inoculation of Cmu successfully promoted bacterial ascension into 728 
the upper reproductive tract. (A) 16S rRNA expression was only detected in the uterine 729 
horn of Cmu-inoculated mice at three different time-points (**P<0.01, ***P<0.001; Mann-730 
Whitney U test). (B-C) Higher cross-sectional area (mm2) was observed in both the oviducts 731 
of Cmu-inoculated mice at three time-points (*P<0.05, **P<0.01, ***P<0.001; unpaired t-732 
test). Data are presented at mean  S.E.M. (n = 8-14).  733 
 734 
Fig 2: mRNA expression of cytokines in the uterine horn of sham- and Cmu-inoculated 735 
mice at 7-, 14- and 21dpi. Data are presented at mean  S.E.M. (n = 7-14; unpaired t-test or 736 
Mann-Whitney U test; *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001). 737 
 738 
Fig 3: mRNA expression of cytokines in the cervix of sham- and Cmu-inoculated mice at 739 
7-, 14- and 21dpi. Data are presented at mean  S.E.M. (n = 7-14; unpaired t-test or Mann-740 
Whitney U test; *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001). 741 
 742 
Fig 4: The contractile force and frequency of spontaneous contractions in the uterine 743 
horn and cervix of sham-inoculated and Cmu-inoculated mice at 7-, 14- and 21 days 744 
post-infection (dpi). (A-C; F-H) Representative traces of spontaneous contractions of mouse 745 
uterine horns and cervices. (D-E) Chlamydia muridarum (Cmu) did not affect the 746 
spontaneous contraction of the uterine horn at 7-, 14- and 21dpi. (I) Cmu infection 747 
significantly reduced the contractile force of the spontaneous contractions of cervix at only 7- 748 




the contractile frequency of the spontaneous contractions in the cervix at the three time-points. 750 
Data are presented as mean  S.E.M. (n = 8-14). 751 
 752 
Fig 5: Cmu infection significantly reduced contractile force and frequency of the uterine 753 
horn to cumulative doses of oxytocin at7dpi. (A, D, G) Representative traces of the 7-, 14- 754 
and 21dpi uterine horns in response to increasing concentrations of oxytocin. (B, E, H) Dose-755 
response curves of the uterine horn responses to cumulative doses of oxytocin (n=6-10; 756 
Nonlinear Regression – Comparison of Fits; ****P<0.0001). (C, F, I) mRNA expression of 757 
Otr receptor in the uterine horns (n=6-12; unpaired t-test or Mann-Whitney U test; **P<0.01). 758 
Data are presented as mean  S.E.M.  759 
 760 
Fig 6: Cmu infection significantly reduced the contractile force of the cervix at 7dpi. (A, 761 
D, G) Representative traces of the 7-, 14- and 21dpi cervices in response to increasing 762 
concentrations of oxytocin. (B, E, H) Dose-response curve of the cervix response to 763 
cumulative doses of oxytocin (n=6-10; Nonlinear Regression – Comparison of Fits; 764 
****P<0.0001). (C, F, I) mRNA expression of Otr receptor in the cervices (n=6-10; unpaired 765 
t-test; ****P<0.0001). Data are presented as mean  S.E.M. 766 
 767 
Fig 7: PGE2 induced relaxation in the uterine horn but induced contraction in the 768 
cervix. (A and B) Representative traces of the uterine horn (A) and cervix (B) in response to 769 
1µM PGE2. (C) The comparison of combined mRNA expression of prostaglandin receptors 770 
in the cervices and uterine horns of sham-inoculated mice in three time-points (n=24-29; 771 





Fig 8: Cmu infection significantly increased the contractile force of the uterine horn to 774 
1µM and 3µM PGF2α at 14- and 21dpi and altered mRNA expression of prostaglandin 775 
receptors. (A, C, E) The change in peak contractile force of the spontaneous contractions of 776 
the uterine horn evoked by 1µM and 3µM PGF2α was compared between the sham- and 777 
Cmu-inoculated mice (n=8-10; unpaired t-test; *P<0.05, **P<0.01). (B, D, F) mRNA 778 
expression of prostaglandin receptors (Ptgfr, Ptger3 and Ptger4) in the uterine horn (n=6-12; 779 
unpaired t test or Mann-Whitney U test; *P<0.01, **P<0.01, ****P<0.0001). Data are 780 
presented as mean  S.E.M. 781 
 782 
Fig 9: Correlation coefficients of inflammatory cytokine gene expression with Otr, Ptgfr 783 
and Ptger4 gene expression in the uterine horn of Cmu-inoculated mice. Numbers in the 784 
figure refer to the correlation coefficients r value. The data was combined from three time-785 
points for correlation analysis. The mRNA expression of Otr and Ptger4 genes was inversely 786 
correlated with the mRNA expression of Il1b and Il6 genes in the uterine horn of Cmu-787 
inoculated mice (n=23; Spearman’s correlation; **P<0.01, ***P<0.001). 788 
 789 
Fig S1 Cmu infection did not alter the responses of the cervix and uterine horn to 60mM 790 
KCl at three time-points.  Data are presented as mean  S.E.M. (n = 8-14). 791 
 792 
Fig S2: Representative traces of uterine contractions to PGF2α at 7-, 14- and 21dpi.  793 
 794 
Fig S3: Representative traces of cervical contractions to PGF2α at 7-, 14- and 21dpi.  795 
 796 





Gene Forward primer Reverse primer 
Hprt 5'-AGGCCAGACTTTGTTGGATTTGAA-3' 5'-CAACTTGCGCTCATCTTAGGCTTT-3' 
16S rRNA 5’-GCGGCAGAAATGTCGTTTT-3’ 5’-CGCTCGTTGCGGGACTTA-3’ 
Stat1 5'-CCCGAATTTGACAGTATGATGA-3' 5'-GAAGGAACAGTAGCAGGAAGGA-3' 
Stat6 5'-GCACCTTGGAGAGCATCTATCAGAG-3' 5'-TTGAGTTCTTCCTGCTTCCGATG-3' 
Ifng 5’-TCTTGAAAGACAATCAGGCCATCA-3’ 5’-GAATCAGCAGCGACTCCTTTTCC-3’ 
Cxcl1 5'-GCTGGGATTCACCTCAAGAA-3' 5'-CTTGGGGACACCTTTTAGCA-3' 
Cxcl2 5'-TGCTGCTGGCCACCAACCAC-3' 5'-AGTGTGACGCCCCCAGGACC-3' 
Il10 5’-AGGCGCTGTCATCGATTTCT-3’ 5’-ATGGCCTTGTAGACACCTTGG-3’ 
Mmp9 5'-CGAACTTCGACACTGACAAGAAGT-3' 5'-GCACGCTGGAATGATCTAAGC-3' 
Il1b 5'-TGGGATCCTCTCCAGCCAAGC-3' 5'-AGCCCTTCATCTTTTGGGGTCCG-3' 
Il6 5'-AGAAAACAATCTGAAACTTCCAGAGAT-3' 5'-GAAGACCAGAGGAAATTTTCAATAGG-3' 
Cxcl15 5’-AAGGAAGTGATAGCAGTCCCAAA-3’ 5’-GCCAACAGTAGCCTTCACCC-3’ 
Tnfa 5'-TCTGTCTACTGAACTTCGGGGTGA-3' 5'-TTGTCTTTGAGATCCATGCCGTT-3' 
Otr 5’-CCTGGAGAGACGAGCATTAGC-3’ 5’-TCATGCCGAGGATGGTTGAG-3’ 
Ptgfr 5’-ATAATGTGCGTCTCCTGCGT-3’ 5’-GCGGAGAGCAAAAAGTGTCG-3’ 
Ptger1 5’-ACGCACACGATGTGGAAATG-3’ 5’-CAGGGAGTTAGAGTTCCAGC-3’ 
Ptger2 5’-GAGAGGACTTCGATGGCAGAG-3’ 5’-AGGTCCCACTTTTCCTTTAGGG-3’ 
Ptger3 5’-ATGTGTGTGCTGTCCGTCTG-3’ 5’-TGTCTTGCATTGCTCAACCG-3’ 
Ptger4 5’-CTCATCTGCTCCATTCCGCT-3’ 5’-GGTTCACAGAAGCAATCCTG-3’ 
Table 1: Forward and reverse primers of selected genes 
 
 Relative increase or decrease in cervical peak force in the presence of agonists  
 7 dpi  14 dpi  21 dpi 
 Sham Cmu  Sham Cmu  Sham Cmu 
n 8 9  8 8  10 10 
1 µM PGF2α 25.68±6.56 32.76±3.58  38.24±6.95 31.37±6.46  28.53±9.26 38.97±13.06 
3 µM PGF2α 37.00±7.15 27.62±4.75  34.53±6.64 27.36±6.82  23.21±5.85 31.57±8.19 
1 µM PGE2 -6.28±3.03 -5.09±4.38  15.50±5.93 25.70±7.27  9.25±7.61 11.65±5.86 
1mM histamine 9.90±4.86 2.60±3.97  1.83±4.18 9.91±5.63  -1.66±2.87 7.43±5.57 
Table 2: Comparison of cervical contractile force in sham-inoculated and Cmu-inoculated mice to 
prostaglandins and histamine. The change in contractile force evoked by agonists as a percentage of 
maximal KCl evoked force. There was no significant difference in the cervical contractions between the 
two groups at these doses. Data are presented as mean ± S.E.M. 
 
 
 Relative increase or decrease in uterine peak force in the presence of agonists 
 7 dpi  14 dpi  21 dpi 
 Sham Cmu  Sham Cmu  Sham Cmu 
n 8 9  8 8  10 10 
1 µM PGE2 -15.34±3.12 -19.50±4.04  -17.63±6.09 -15.50±5.24  -24.40±4.50 -31.31±5.70 
1 mM histamine 0.57±2.60 4.87±4.03  9.01±3.48 15.91±3.36  12.69±3.30 13.36±4.49 
Table 3: Comparison of uterine contractile force in sham-inoculated and Cmu-inoculated to 
prostaglandins and histamine. The change in contractile force evoked by agonists as a percentage of 
maximal KCl evoked force. There was no significant difference in the uterine contractions at these doses. 
Data are presented as mean ± S.E.M. 
 
 









